Mars, Incorporated, which is a worldย leader when it comes to snacking, food and pet care products and services, and also theย manufacturer of over 40 U.S. household favourites such asย M&MโSยฎ, CHEEZ-ITยฎ, Benโs Originalโข, and PEDIGREEยฎ, as well as Royal Caninยฎ, on November 10, 2026,ย announced its intention to put inย around $1.4b in its U.S. manufacturing and operations presence in 2027 โ highest US manufacturing investment made by Mars in one year. The pledge is built on over $9 billion invested in domestic operations ever sinceย 2017.
According to Claus Aagaard, CFO of Mars, Incorporated, โAs Mars marks 115 years in business, our commitment to American manufacturing has never been stronger. Ninety-four percent of the Mars products sold in the U.S. are made here, reflecting decades of investment in our people, operations and the communities in which we do business. Our continued investments build for the future โ expanding our manufacturing capabilities, accelerating growth across our portfolio and services and ensuring we can meet the evolving needs of consumers for generations to come.โ
It is worth noting that theย $1.4 billion contract which apparently is the highest US manufacturing investment made by Mars includes funding by the company of overย $34 million to establish 4 new cutting-edge Mars Veterinary Health hospitals early in 2027. Three new BluePearlโข Pet Hospitals in Ellicott City, MD, Austin and Katy, TX, along with a new Banfieldยฎ Pet Hospital in Wilmington, NC, will increase opportunities for high-quality veterinary care throughout the nation. The facilities will offer accessibility to cutting-edge emergency and speciality veterinary care, introduce innovative medical services to flourishing communities, and foster the growth of competent veterinary professionals.
Apparently, theย new pet hospitals will create as many as 195 new jobs.
Marsโ continued investment over the last 10 years demonstrates the business’s long-standing commitment to American manufacturing, creativity, and sustainable economic growth in the communities where they operate. Mars is also accelerating the growth of its snacking portfolio with ongoing capital investments that allow for noteworthy scaling of products and innovations. Investments are also being used to modernize manufacturing at locations where Mars has been operating for a long time, adding to its supply chain robustness while enhancing operational performance and geographic accessibility to its services.
Recent 2026 investments by the company include โย
- The Trรผ Frรผยฎ brand is expanding its business operations in Salt Lake City, UT, where it has been based since 2025. Mars has alreadyย committed $60 million to construct 2 dedicated manufacturing lines for Trรผ Frรผ at the Salt Lake City factory of the company, a $240 million facility that opened in 2025ย to make Natureโs Bakery products. In addition to producing overย 1 billion Natureโs Bakery snack bars yearly, the plant will have the required capacity to make 17 million Trรผ Frรผ frozen items per year.
- The Mars facility in Waco, Texas,ย celebrates 50 years of operation in November 2026. They have alreadyย invested $165 million in the site since 2024, with current capital projects heavily geared toward efficiency of energy and operational performance. The facility produces over 56 billion pieces of SNICKERSยฎ and STARBURSTยฎ as well as SKITTLESยฎ candies annually and drives innovative recipe development and format advancement for the brands. The facility has recently backed the launch of the brand new SNICKERS Xtreme Almond bar and STARBURST Sour innovations.
- Mars is bringing manufacturing of its fast-growing TEMPTATIONSยฎ Lickable Treats to the U.S. through a $49 million investment in a Mars wet pet food facility located inย Columbus, Ohio. The investment will add a capacity to produce well over 400 million Lickable Treat pouches per year and bring technology upgrades such as state-of-the-art mixing and filling. Notably, since 2022, Mars has contributed $162 million to the location.
Mars, whose global headquarters are in the U.S., employs approximately 80,000 U.S. associates who assist in excess of 60 factories and research labs, as well as offices, in addition to more than 2,000 veterinary clinics and hospitals throughout the country. Mars will keep continuing to strategically allocate capital in manufacturing to modernize its full portfolio of U.S. facilities, with 15 new facilities added over in 2025ย via the Kellanova acquisition.

